Circular Dichroism (CD) Spectrometer Market Size and Forecast – 2026 – 2033
The Global Circular Dichroism (CD) Spectrometer Market size is estimated to be valued at USD 256 million in 2026 and is expected to reach USD 398 million by 2033, exhibiting a compound annual growth rate (CAGR) of 6.1% from 2026 to 2033.
Global Circular Dichroism (CD) Spectrometer Market Overview
Circular dichroism spectrometers are analytical instruments used to study the structural properties of chiral molecules. These products measure differences in absorption of left- and right-circularly polarized light, providing insights into protein secondary structures and molecular conformations. CD spectrometers are widely used in pharmaceutical research, biotechnology, and academic laboratories. Key features include high sensitivity, wavelength accuracy, and compatibility with biological samples.
Key Takeaways
Bench-top CD spectrometers dominate the Instrument Type segment with 48% market share due to their comprehensive application in pharmaceutical R&D and industrial labs. Portable devices demonstrate the fastest growth owing to increasing demand for on-site and field applications.
Pharmaceutical & Biotechnology application continues to lead the market segments, capitalizing on the growing imperatives of chiral drug development and molecular structure analysis.
North America remains the dominating region, contributing over 35% market share, facilitated by strong industrial presence, favorable government policies, and substantial pharmaceutical R&D expenditure.
Asia Pacific is the fastest-growing region propelled by rapid industrialization, increasing academic research infrastructure, and expanding biopharmaceutical manufacturing capacity, with a CAGR above 7% projected.
Circular Dichroism (CD) Spectrometer Market Segmentation Analysis

To learn more about this report, Download Free Sample
Circular Dichroism (CD) Spectrometer Market Insights, By Instrument Type
Bench-Top dominates the market share. Bench-top instruments are favored for their extensive wavelength coverage and multifunctional capabilities, making them indispensable in pharmaceutical and chemical laboratories. They provide superior sensitivity and spectral resolution essential for complex biomolecular studies, accounting for 48% of the overall market share. Portable CD spectrometers, meanwhile, represent the fastest-growing subsegment owing to increasing demand for on-site molecular analysis across environmental monitoring and field research. Their compact size and ease of use facilitate versatile applications beyond traditional laboratory settings.
Circular Dichroism (CD) Spectrometer Market Insights, By Application
Pharmaceuticals & Biotechnology are dominating the market share. This segment benefits from increasing chiral drug approvals and stringent regulatory requirements mandating detailed protein and molecular structural analysis. Pharmaceutical companies represent the primary end users, seeking enhanced CD spectrometer solutions to improve drug efficacy and safety. Academic & Research Institutes, the fastest growing subsegment, are expanding investments in cutting-edge spectrometers to support proteomics and molecular biology research. The Chemical Industry utilizes CD spectrometry for enantiomeric purity assessments, while the Cosmetics sector increasingly applies CD methods for stereochemistry-related quality control.
Circular Dichroism (CD) Spectrometer Market Insights, By Technology
Near-UV and Far-UV CD Spectrometers dominate the market share. These subsegments remain integral due to their expansive usability across diverse biomolecular materials, granting critical insights into secondary and tertiary protein structures. Near-UV and Far-UV CD spectrometers have refined sensitivity and broad spectral coverage, making them instrumental in both pharmaceutical and academic research. The Vacuum Ultraviolet (VUV) segment is the fastest growing due to advancements that allow exploration into previously inaccessible molecular transitions, enabling detailed chiral analysis at deeper energy levels.
Circular Dichroism (CD) Spectrometer Market Trends
The Circular Dichroism (CD) Spectrometer market is witnessing transformative technological advancements focusing on integration with AI and cloud computing for real-time spectral data analysis.
For example, in 2025, several companies introduced instruments equipped with AI-powered algorithms to streamline protein secondary structure determination, enhancing speed and accuracy in pharmaceutical research.
Another notable trend is the surge in demand for portable and miniaturized CD spectrometers driven by on-field applications in environmental and agricultural studies, which saw a 20% sales increase in 2025 compared to preceding years.
Furthermore, the integration of Circular Dichroism spectroscopy with complementary analytical techniques such as NMR and mass spectrometry is redefining multi-dimensional molecular analysis, leading to enhanced trustworthiness of results and expanded industry use cases.
Circular Dichroism (CD) Spectrometer Market Insights, By Geography

To learn more about this report, Download Free Sample
North America Circular Dichroism (CD) Spectrometer Market Analysis and Trends
In North America, the dominance in the Circular Dichroism (CD) Spectrometer market stems from strong pharmaceutical R&D infrastructure, well-established biotechnology hubs, and progressive regulatory frameworks incentivizing high-quality chiral compound analysis. The region accounts for over 35% of the market share and hosts several leading manufacturers and end users, including US-based biotech companies actively investing in advanced CD instrumentation. This environment fosters continuous technology enhancement and competitive pricing.
Asia Pacific Circular Dichroism (CD) Spectrometer Market Analysis and Trends
Meanwhile, the Asia Pacific exhibits the fastest growth with a CAGR exceeding 7%, driven by expanding academic research institutions, increasing government support for biotechnology, and the rapid growth of the pharmaceutical manufacturing sector, particularly in China and India. The region benefits from ongoing investments in instrumentation and the establishment of high-tech industrial parks facilitating faster product development and adoption.
Circular Dichroism (CD) Spectrometer Market Outlook for Key Countries
USA Circular Dichroism (CD) Spectrometer Market Analysis and Trends
The USA's Circular Dichroism spectrometer market is propelled by robust pharmaceutical and biotech R&D activities. Major players headquartered in the country have introduced automated and cloud-based CD spectrometers, enhancing research efficiency. Government funding through initiatives like the National Institutes of Health (NIH) continues to underpin academic adoption. Market momentum is also supported by the presence of global pharmaceutical companies accelerating chiral drug development, amplifying demand for precise analytical instrumentation.
China Circular Dichroism (CD) Spectrometer Market Analysis and Trends
China’s growing pharmaceutical manufacturing and research landscape has spurred demand for high-quality CD spectrometers. Domestic manufacturers alongside international firms have expanded regional supply chains, fueling local adoption primarily in the Guangdong, Shanghai, and Beijing regions. Strategic collaborations between universities and biotech startups to improve instrumentation innovation are evident. Government policies emphasizing innovation and high-tech industries serve as a catalyst for sustained market growth.
Analyst Opinion
The supply capacity of Circular Dichroism spectrometers has seen a marked increase with manufacturers enhancing production capabilities by over 12% in 2025 to meet rising global demand. This increase has contributed significantly to market growth by reducing lead times for customized instruments, crucial for pharmaceutical R&D sectors.
Pricing trends in the CD spectrometer market have demonstrated mild upward adjustments averaging 3%-4% annually from 2023 through 2026, reflecting improved instrument functionalities and integration with advanced software tools facilitating enhanced data analytics and spectral resolution. For instance, new spectrometers by leading market players incorporate AI-assisted data interpretation, justifying higher price points.
Demand across various use cases continues to diversify, with notable expansion observed in biotechnology applications for protein folding studies and in the cosmetics industry for chiral compound formulation. Import volumes of high-precision CD spectrometers have increased by 15% in North America over the last two years, underpinning the broadening market scope.
Nano-size indicators such as growth in miniaturized CD spectrometers have accelerated market penetration in academic and clinical research. Consumer interest in portable and benchtop devices surged by nearly 18% in 2025, evidencing end-users’ preference for compact, user-friendly systems without compromising analytical accuracy.
Market Scope
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 256 million |
| Historical Data for: | 2021 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.1% | 2033 Value Projection: | USD 398 million |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: | Bio-Logic SAS, Analytik Jena AG, Chirascan, Hitachi High-Tech Corporation, Olis, Inc., Pi-star Technologies, JAS Instruments, Specac Ltd., ThorLabs, Inc., Ocean Optics, Inc. | ||
| Growth Drivers: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Circular Dichroism (CD) Spectrometer Market Growth Factors
Rising pharmaceutical and biotech R&D investments – The growing pipeline of chiral drugs requiring precise molecular characterization has propelled demand for CD spectrometers, particularly in North America and Europe. Technological advancements** – Innovations in instrument sensitivity and expanded wavelength ranges have enabled more complex biomolecular investigations, fueling market expansion. Increased adoption in academic research – Universities and research institutes worldwide continue upgrading equipment portfolios to include state-of-the-art CD spectrometry, supported by rising government funding. Regulatory focus on quality control – Stricter guidelines for chiral purity assessment in drug manufacturing have augmented sales of high-precision CD spectrometers globally.
Circular Dichroism (CD) Spectrometer Market Development
In 2024, Bio-Logic Science Instruments, in collaboration with Hinds Instruments, launched EKKO, the world’s first high-throughput circular dichroism (HT-CD) microplate reader designed for 96-well plates. This innovation enables rapid, parallel chiral and secondary-structure analysis of biomolecules, dramatically reducing analysis time compared with traditional single-cuvette CD systems and supporting accelerated workflows in biopharmaceutical discovery and structural biology research.
In 2024, JASCO Corporation introduced HTCD Plus, an advanced high-throughput circular dichroism system featuring automated sampling for up to 192 samples. The platform is optimized for high-speed screening in vaccine development, protein characterization, and drug discovery, allowing researchers to efficiently evaluate conformational stability and structural changes across large sample sets with minimal manual intervention.
Key Players
Leading Companies of the Market
Bio-Logic SAS
Analytik Jena AG
Chirascan
Hitachi High-Tech Corporation
Olis, Inc.
Pi-star Technologies
JAS Instruments
Specac Ltd.
ThorLabs, Inc.
Ocean Optics, Inc.
Several leading companies have adopted robust growth strategies including collaborative product innovation and strategic acquisitions to reinforce market position. For example, JASCO Corporation’s launch of integrated CD spectrometers equipped with superior automation features increased their U.S. market share by 8% in 2025. Similarly, Applied Photophysics Ltd. expanded its distribution channels across Asia Pacific in 2026, enhancing regional penetration significantly.
Circular Dichroism (CD) Spectrometer Market Future Outlook
The future outlook for the CD spectrometer market is positive as demands for structural characterization grow in drug discovery, biopharmaceutical development, and materials science. Innovations in source technologies, temperature control accessories, and higher signal-to-noise performance will enhance sensitivity and expand application ranges. Integration with computational modeling and AI-based analysis will improve the interpretation of complex biological datasets. Portable and compact CD spectrometers may open new opportunities in field research and industrial quality control. As multidisciplinary research intensifies—especially in protein therapeutics, biopolymers, and structural biology—CD spectroscopy will continue to play a vital role in understanding molecular conformation.
Circular Dichroism (CD) Spectrometer Market Historical Analysis
The circular dichroism (CD) spectrometer market stems from foundational research in chiroptical spectroscopy developed in the mid-20th century, which enabled scientists to study the optical activity of chiral molecules. Early CD instruments were limited in sensitivity and wavelength range, restricting applications to small-molecule research. With advances in light sources, detector technology, and signal processing in the late 20th century, CD spectrometers became indispensable tools for examining the secondary and tertiary structures of proteins, nucleic acids, and other biomolecules. Integration with modern analytical workflows and improvements in software for data interpretation further expanded usage across academic, pharmaceutical, and biotechnology laboratories.
Sources
Primary Research Interviews:
Analytical Chemists
Structural Biologists
Pharmaceutical Researchers
Lab Instrument Specialists
Academic Scientists
Databases:
OECD Science Data
NIH Research Tools
UN Technology Data
Magazines:
Lab Manager
Scientific Instruments Review
Analytical Science Magazine
BioTechniques
Spectroscopy Online
Journals:
Applied Spectroscopy
Journal of Molecular Biology
Biophysical Journal
Analytical Chemistry
Protein Science
Newspapers:
Financial Times (Science)
Reuters Technology
The Guardian (Science)
Bloomberg Technology
Nikkei Asia
Associations:
American Chemical Society
Biophysical Society
International Union of Pure and Applied Chemistry
Society for Applied Spectroscopy
European Biophysical Societies Association
Share
Share
About Author
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Select a License Type
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients